SWOT Analysis for Neurometrix Inc.

MACD Crossover Above Signal Line
Price crossing above SMA20 today, and greater than SMA5
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
MACD crossed above zero line previous end of day
MACD crossed above signal line previous end of day
Near 52 Week High
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
High Volume, High Gain
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Volume Shockers
Biggest Price Gainers from Open
Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
Negative profit growth, promoters decreasing shareholding QoQ
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Declining profits every quarter for the past 2 quarters
Declining Revenue every quarter for the past 4 quarters